Please Wait.....
Report
India In-Vitro Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-06-01 I 90 Pages I Mordor Intelligence
India In-Vitro Diagnostics Market Analysis
The India in-vitro diagnostics market is valued at USD 1.82 billion in 2025 and is forecast to reach USD 2.51 billion by 2030, growing at a 6.58% CAGR. The expansion reflects stronger clinical focus on evidence-based care, wider health-insurance coverage, and public investments that are widening test availability. Rapid molecular methods, artificial intelligence-enabled automation, and digital health linkages are lifting laboratory productivity while shrinking turnaround times. At the same time, the dual burden of infectious and chronic diseases is broadening test menus, and organized diagnostic chains are rolling tier-2 and tier-3 city networks into hub-and-spoke systems that improve access and pricing. Constraints persist around cold-chain logistics, fragmented regulation, and heavy reliance on imported instruments, but technology transfer, Make-in-India incentives and portable cooling solutions are beginning to narrow these gaps across the India in-vitro diagnostics market.
India In-Vitro Diagnostics Market Trends and Insights
Rising Dual Burden of Communicable & Non-Communicable Diseases Necessitating Early Diagnostics
Tuberculosis still represents 27% of global cases traced to India, prompting a shift from microscopy to rapid molecular assays that offer higher sensitivity and same-day results. National Family Health Survey data show anemia prevalence of 57% among women and 67% among children under five, driving hematology test demand. Parallel growth of diabetes, now affecting 101 million citizens, and rising cardiovascular morbidity are pushing clinical chemistry and immunoassay volumes. Laboratories therefore broaden menus to run infectious disease panels alongside lipid, HbA1c, and cardiac marker testing on integrated platforms. Precision-oriented test adoption is accelerating in oncology as liquid biopsy assays identify actionable mutations without invasive biopsies, underlining why comprehensive diagnostics sit at the centre of India in-vitro diagnostics market development.
Expanding Health-Insurance Penetration & Disposable Incomes Enhancing Test Affordability
Insurance coverage has climbed from 25% to 51% of the population through flagship schemes such as Pradhan Mantri Jan Arogya Yojana. Reimbursement of laboratory procedures is lowering out-of-pocket spending and steering patients toward accredited sites. Growing volumes help labs amortise investments in high-throughput PCR, NGS, and chemiluminescence platforms, enabling price cuts that lure middle-income segments in tier-2 urban belts. Insurers are tightening quality criteria, compelling smaller centres to secure NABL accreditation or partner with organised chains. The resulting virtuous cycle of affordability, quality, and scale improves market depth across the India in-vitro diagnostics market.
Limited Cold-Chain & Logistics Infrastructure Restricting Rural Reagent Distribution
One-fifth of temperature-sensitive health products degrade because trucks and storage points cannot sustain 2-8C. Portable battery-powered units like Phloton hold reagents at 4-6C for 10 hours, but deployment is nascent. Widespread solar refrigeration roll-outs and passive insulated packaging are being tested to widen rural reach. Cold-chain gaps particularly hinder molecular and immunoassay expansion, slowing rural contribution to the India in-vitro diagnostics market.
Other drivers and restraints analyzed in the detailed report include:
Government Investments in Public Laboratory Infrastructure under National Health Mission / Adoption of High-Throughput Automation & AI in Laboratories Elevating Efficiency / Fragmented Regulatory Approval Pathway Increasing Time-to-Market /
For complete list of drivers and restraints, kindly check the Table Of Contents.
List of Companies Covered in this Report:
Abbott Laboratories / Roche / Siemens Healthineers / Transasia Bio-Medicals / Thermo Fisher Scientific / Beckton Dickinson / bioMerieux / Danaher / Beckton Dickinson / Arkray / Bio-Rad Laboratories / Agappe Diagnostics / Mylab Discovery Solutions / J?Mitra & Co. Pvt Ltd / HLL Lifecare Ltd (Hindlabs) / SRL Diagnostics (Fortis Healthcare) / Dr. Lal PathLabs Ltd / Metropolis Healthcare Ltd / Molbio Diagnostics (Truenat) / Seegene /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Dual Burden of Communicable & Non-Communicable Diseases Necessitating Early Diagnostics
4.2.2 Expanding Health-Insurance Penetration & Disposable Incomes Enhancing Test Affordability
4.2.3 Government Investments in Public Laboratory Infrastructure under National Health Mission
4.2.4 Adoption of High-Throughput Automation & AI in Laboratories Elevating Efficiency
4.2.5 Integration of Digital Health Ecosystems (LIS, Telepathology) Broadening Access to Testing
4.2.6 Expansion of Private Lab Chains Driving Centralized Testing
4.3 Market Restraints
4.3.1 High Out-of-Pocket Healthcare Spending Creating Price Sensitivity
4.3.2 Dependence on Imported Instruments & Raw Materials Exposing Currency Risk
4.3.3 Limited Cold-Chain & Logistics Infrastructure Restricting Rural Reagent Distribution
4.3.4 Fragmented Regulatory Approval Pathway Increasing Time-to-Market
4.4 Supply-Chain Analysis
4.5 Regulatory Outlook
4.6 Porter's Five Forces
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitutes
4.6.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Test Type
5.1.1 Clinical Chemistry
5.1.2 Immuno-Diagnostics
5.1.3 Haematology
5.1.4 Molecular Diagnostics
5.1.5 Coagulation
5.1.6 Microbiology
5.1.7 Others
5.2 By Technology
5.2.1 Polymerase Chain Reaction (PCR)
5.2.2 Reverse Transcription PCR (RT-PCR)
5.2.3 Next-Generation Sequencing
5.2.4 Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.5 Chemiluminescence
5.2.6 Rapid Antigen / Lateral Flow
5.3 By Product
5.3.1 Instruments / Analysers
5.3.2 Reagents & Kits
5.3.3 Software & Services
5.4 By Usability
5.4.1 Disposable IVD Devices
5.4.2 Re-usable IVD Devices
5.5 By Testing Site
5.5.1 Central Laboratory Testing
5.5.2 Point-of-Care Testing
5.6 By Specimen Type
5.6.1 Blood
5.6.2 Urine
5.6.3 Saliva
5.6.4 Other Body Fluids
5.7 By Application
5.7.1 Infectious Disease
5.7.2 Diabetes
5.7.3 Cancer / Oncology
5.7.4 Cardiology
5.7.5 Auto-immune Disorders
5.7.6 Nephrology
5.7.7 Others
5.8 By End-user
5.8.1 Diagnostic Laboratories
5.8.2 Hospitals & Clinics
5.8.3 Home-care & Self-testing
5.8.4 Academic & Research Institutes
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.3.1 Abbott Laboratories
6.3.2 F. Hoffmann-La Roche AG
6.3.3 Siemens Healthineers
6.3.4 Transasia Bio-Medicals Ltd
6.3.5 Thermo Fisher Scientific
6.3.6 Beckman Coulter, Inc.
6.3.7 bioMerieux SA
6.3.8 Danaher Corporation (Cepheid)
6.3.9 Becton, Dickinson & Company
6.3.10 Arkray, Inc.
6.3.11 Bio-Rad Laboratories, Inc.
6.3.12 Agappe Diagnostics
6.3.13 Mylab Discovery Solutions
6.3.14 J?Mitra & Co. Pvt Ltd
6.3.15 HLL Lifecare Ltd (Hindlabs)
6.3.16 SRL Diagnostics (Fortis Healthcare)
6.3.17 Dr. Lal PathLabs Ltd
6.3.18 Metropolis Healthcare Ltd
6.3.19 Molbio Diagnostics (Truenat)
6.3.20 Seegene Inc.
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security